🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The HIV epidemic represents one of the greatest health challenges worldwide...
Status
Recruiting
Location
Hospital Universitario Ramón y Cajal
Start Date
2025-05-30
Trial ID
NCT06640192
Treatments Being Tested
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Status
Completed
Location
UAB HIVTR-CCR5 Non-Network CRS
Start Date
2017-01-01
Trial ID
NCT02741323
An open label study to evaluate an interaction between maraviroc and ralteg...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-02
Trial ID
NCT00666705
Treatments Being Tested
The presence of a pool of cells latently infected by HIV-1 in patients taki...
Status
Completed
Location
Hospital Universitario Ramon Y Cajal
Start Date
2008-03
Trial ID
NCT00795444
Treatments Being Tested
CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Status
Completed
Location
University Southern California
Start Date
2008-10-20
Trial ID
NCT00925756
Treatments Being Tested
The objective of this study is to discover a new approach in which human im...
Status
Completed
Location
University of California San Francisco
Start Date
2009-11
Trial ID
NCT00976404
Treatments Being Tested
To provide access to maraviroc to patients who have limited or no therapeut...
Status
Completed
Location
The University of Alabama
Start Date
2007-02
Trial ID
NCT00426660
Treatments Being Tested
The objective of this study was to estimate the effects of a single dose of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-04
Trial ID
NCT00853840
Treatments Being Tested
Maraviroc (UK-427,857), a selective and reversible CCR5 coreceptor antagoni...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-11
Trial ID
NCT00098293
This will be an open-label, parallel group, multiple dose study in approxim...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-11-06
Trial ID
NCT02625207
Treatments Being Tested